Drugs / TTP435
last change Dec 2009 re-read 3 minutes ago

TTP435

targets AGRP via inhibition

Developed for
obesity disorder
Investigated by
vTv Therapeutics

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00779519 Feb → Dec 2009 obesity disorder vTv Therapeutics Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TTP435 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00779519 ↗
Action Inhibit “inhibiting the activity of AgRP” NCT00779519 ↗
Target AGRP “inhibiting the activity of AgRP” NCT00779519 ↗